Brokerage Ratings: Cummins, Hindalco, PB Fintech Updates
Indian financial professionals monitor stock market data.
Key Highlights
Discover fresh brokerage ratings and target price revisions for Cummins, Hindalco Novelis, and PB Fintech following their Q1FY27 earnings reports. Get expert market insights.
Leading brokerages have issued updated ratings and target prices for a range of Indian equities ahead of today’s trade on August 6, 2026. This follows Q1FY27 performance and business outlooks across several key companies.
Cummins India: Mixed Analyst Views
JPMorgan maintains a “Neutral” rating for Cummins, setting a target price of Rs 5882. The firm cited weak Q1FY27 margins and the Managing Director’s resignation as key concerns.
HSBC, conversely, holds a “Buy” rating with a target price of Rs 6500. While acknowledging margin pressure, HSBC noted strong execution and steady business momentum.
Citi also maintains a “Buy” rating, assigning a target price of Rs 6700. Citi attributed the observed lower margins to commodity headwinds.
Hindalco Novelis: Operational Headwinds Easing
Kotak has issued a “Buy” rating for Hindalco Novelis, with a target price of Rs 1120. The brokerage anticipates subsiding operational headwinds and an on-schedule Oswego ramp-up.
Morgan Stanley (MS) rates Hindalco Novelis “Overweight,” projecting a target price of Rs 1140. MS views FY27 as a transitional year, noting better-than-expected core and the Bay Minette ramp-up as a future catalyst.
Macquarie maintains a “Neutral” stance, setting a target price of Rs 1080. The firm observed a modest EBITDA beat and ongoing expansion efforts, with potential upside from higher aluminum prices.
Key Brokerage Calls
- Berger Paints: MS rates “Underweight” with a target price of Rs 429.
- Aurobindo Pharma: Macquarie rates “Underperform” with a target price of Rs 1300, citing a marginal Q1 EBITDA beat due to lower R&D costs and mixed geographical performance.
Fintech: Growth vs. Valuation
Macquarie maintains an “Outperform” rating for PB Fintech, with a target price of Rs 1950. The brokerage highlighted strong growth momentum and in-line Q1 profitability.
Nomura holds a “Neutral” rating, setting a target price of Rs 1590. Nomura cited robust momentum, Q1 results surpassing estimates, and improved take rates for insurance platforms.
Morgan Stanley (MS) maintains an “Underweight” rating for PB Fintech, despite a good Q1, with a target price of Rs 1215. MS cited expensive valuation and potential regulatory risks on commissions.
Metropolis and Cohance Life Updates
- Metropolis: MS rates “Equal-weight”, increasing target price to Rs 614 from Rs 588. This was driven by healthy Q1 volume growth and management’s FY27 revenue growth guidance.
- Cohance Life: Macquarie rates “Outperform” with a target price of Rs 1150, despite a weaker Q1. Management anticipates a sequential recovery.
- Cohance Life: Jefferies rates “Underperform”, raising target price to Rs 350 from Rs 300. The firm cited continued sales declines and challenges across divisions.
Navin Fluorine: Divergent Outlooks
Jefferies maintains a “Buy” rating for Navin Fluorine, hiking the target price to Rs 9045 from Rs 8700. This is based on a Q1 beat, a strong CDMO pipeline, and new capital expenditure initiatives.
Citi, conversely, maintains a “Sell” rating, increasing the target price to Rs 7200 from Rs 6500. Citi cited an unfavorable risk-reward profile and potential downside in R32 pricing.
Tenneco Clean: Citi rates “Buy” with a target price of Rs 650. Q1 results slightly exceeded estimates despite commodity price increases, supported by new order wins.
The diverse recommendations underscore varying analyst perspectives on Q1FY27 performance and future growth trajectories for these Indian equities, reflecting both opportunities and ongoing challenges in the market.